WINDTREE THERAPEUTICS INC /DE/ earns about -303% on invested capital, but has diluted owners by 211% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below. Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | −$32.6M1 | −$67.6M2 | −$39.2M3 | −$20.3M4 | −$1.79M4 |
| Operating cash flow | −$25.3M5 | −$23.7M6 | −$19.5M7 | −$13.4M8 | −$15.4M8 |
| Capital expenditure | $291,0009 | $279,00010 | $13,00011 | $15,00012 | $12,00012 |
| Free cash flow (derived) | −$25.6M5,9 | −$23.9M6,10 | −$19.5M7,11 | −$13.5M8,12 | −$15.4M8,12 |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $16.9M13 | $22.3M14 | $6.17M15 | $4.32M16 | $1.78M16 |
| Diluted shares | 16.9M | 495,000 | 630,000 | 4.3M | 52.6M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom). A derived or summed figure cites every filing line it was built from.
10 shares is a claim on $1.9 of net worth that earned you −$0.34 and generated −$2.93 of cash last year.
It earned an average -303% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 211% over 5 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
This page is free, and so is every other company on MeritValue.
Connect the MeritValue MCP server to Claude or another MCP client, ask about WINDTREE THERAPEUTICS INC /DE/, and get these exact figures with their filing receipts — not an improvised DCF.
Get a free key →Pull the companies with a published value under any model (up to 500 a request, filtered by data completeness) into your own sheet or agent. Screening is what Analyst adds, at $9/month.
See pricing →Follow WINT and keep your own price beside the value. The same engine, with the same receipts.
MeritValue on the App Store →- 10-K filed 2022-03-31 · period ending 2020-12-31 · accession 0001437749-22-007757 (NetIncomeLoss)
- 10-K filed 2023-03-31 · period ending 2021-12-31 · accession 0001437749-23-008864 (NetIncomeLoss)
- 10-K filed 2024-04-16 · period ending 2022-12-31 · accession 0001437749-24-012210 (NetIncomeLoss)
- 10-K filed 2025-04-15 · periods ending 2023-12-31, 2024-12-31 · accession 0001437749-25-012093 (NetIncomeLoss)
- 10-K filed 2022-03-31 · period ending 2020-12-31 · accession 0001437749-22-007757 (NetCashProvidedByUsedInOperatingActivities)
- 10-K filed 2023-03-31 · period ending 2021-12-31 · accession 0001437749-23-008864 (NetCashProvidedByUsedInOperatingActivities)
- 10-K filed 2024-04-16 · period ending 2022-12-31 · accession 0001437749-24-012210 (NetCashProvidedByUsedInOperatingActivities)
- 10-K filed 2025-04-15 · periods ending 2023-12-31, 2024-12-31 · accession 0001437749-25-012093 (NetCashProvidedByUsedInOperatingActivities)
- 10-K filed 2022-03-31 · period ending 2020-12-31 · accession 0001437749-22-007757 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K filed 2023-03-31 · period ending 2021-12-31 · accession 0001437749-23-008864 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K filed 2024-04-16 · period ending 2022-12-31 · accession 0001437749-24-012210 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K filed 2025-04-15 · periods ending 2023-12-31, 2024-12-31 · accession 0001437749-25-012093 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K filed 2022-03-31 · period ending 2020-12-31 · accession 0001437749-22-007757 (CashAndCashEquivalentsAtCarryingValue)
- 10-K filed 2023-03-31 · period ending 2021-12-31 · accession 0001437749-23-008864 (CashAndCashEquivalentsAtCarryingValue)
- 10-K filed 2024-04-16 · period ending 2022-12-31 · accession 0001437749-24-012210 (CashAndCashEquivalentsAtCarryingValue)
- 10-K filed 2025-04-15 · periods ending 2023-12-31, 2024-12-31 · accession 0001437749-25-012093 (CashAndCashEquivalentsAtCarryingValue)